Laurus Master Funds

Laurus Labs is a leading research-driven pharmaceutical and biotechnology company headquartered in India, specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDF), and recombinant biotech products. The company holds a dominant global position in the supply of anti-retroviral (ARV) APIs for HIV/AIDS treatment and has significant operations in oncology, cardiovascular, and anti-diabetic therapeutic areas. Through its subsidiary Laurus Bio (formerly Richcore Lifesciences), the company has expanded into large-scale precision fermentation and animal-origin-free recombinant proteins, catering to the vaccine, insulin, and regenerative medicine industries. Laurus Labs operates as a fully integrated player with multiple state-of-the-art manufacturing facilities and a robust Contract Development and Manufacturing Organization (CDMO) division serving global pharmaceutical majors.